We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Rapid, Paper-Based Test Detects Coronavirus in Sewage and Wastewater

By LabMedica International staff writers
Posted on 06 Apr 2020
A team of British researchers has developed a rapid test to detect the COVID-19 virus, SARS-CoV-2, in sewage and wastewater as a means for gauging the level of infection within the community.

One of the characteristics of COVID-19 is that the virus can be spread by individuals who are not symptomatic, having neither fever nor signs of infection. More...
Lacking the ability to screen these asymptomatic patients quickly and effectively, health authorities have no way of predicting the optimum time to reduce the risk of disease transmission by implementing effective quarantine measures. Thus, tracing unknown COVID-19 sources, fast and accurate screening of potential virus carriers, and diagnosis of asymptomatic patients are crucial steps for intervention and prevention at an early stage.

In this regard, investigators at Cranfield University (United Kingdom) developed a wastewater-based epidemiology (WBE) approach to provide a rapid way to predict the potential spread of COVID-19 by screening for viral biomarkers in feces and urine that enter the sewer system from disease carriers.

This concept – a paper-based rapid diagnostic device for detection of coronavirus – is an adaption of technology that had been successfully used for rapid veterinary diagnosis in India and for detection of malaria parasites in blood among rural populations in Uganda.

In practice, the paper device is folded and unfolded in steps to filter the nucleic acids of the virus from wastewater samples. Preloaded reagents in the device detect whether the nucleic acid from SARS-CoV-2 is present. Results are visible to the naked eye: a green circle indicating positive and a blue circle negative. The paper analytical devices are easy to stack, store, and transport because they are thin and lightweight, and can also be incinerated after use, reducing the risk of further contamination.

Senior author Dr. Zhugen Yang, lecturer in sensor technology at Cranfield University, said, "In the case of asymptomatic infections in the community or when people are not sure whether they are infected or not, real-time community sewage detection through paper analytical devices could determine whether there are COVID-19 carriers in an area to enable rapid screening, quarantine, and prevention. If COVID-19 can be monitored in a community at an early stage through WBE, effective intervention can be taken as early as possible to restrict the movements of that local population, working to minimize the pathogen spread and threat to public health."

The paper-based COVID-19 detection device was described in the March 23, 2020, online edition of the journal Environmental Science & Technology.

Related Links:
Cranfield University


Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Sample Transportation System
Tempus1800 Necto
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.